Novozymes A-S (B) Aktie
50,04
EUR
+0,30
EUR
+0,60
%
45,56
CHF
-0,08
CHF
-0,16
%
Werbung
Novozymes A-S (B) Aktie Analyse
| 03.09.12 | Novozymes A-S (B) buy | ING | |
| 28.08.12 | Novozymes A-S (B) overweight | Morgan Stanley | |
| 09.08.12 | Novozymes A-S (B) overweight | Morgan Stanley | |
| 19.06.12 | Novozymes A-S (B) overweight | Morgan Stanley | |
| 17.11.11 | Novozymes A-S (B) overweight | Morgan Stanley |
Werbung
Werbung